An increase in the number of hospital-acquired infections, especially in the developing and underdeveloped economies has surged the demand in the hospital-acquired control market. Different emerging economies such as India, China, South Africa, Brazil, and Mexico are witnessing a surge in the number of under-served patients. Economic development in these regions is creating scopes of the growth for the manufacturers on the back of a large patient pool. Growth in medical expenditure and infrastructure encouraged by the governments of the respective economies is enhancing the adoption rate of sophisticated medical devices, generating substantial revenue in the market. High demand for devices such as endoscope reprocessing devices which are capable of disinfecting medical devices is pushing ahead the boundaries of growth of the market. Innovations focused on avoiding cross contaminations and enhancing the patients' safety are gaining preference in the medical sector.
Major market players are investing in the growing markets such as the US and UK. The companies are leveraging innovative technologies to revolutionize the cleaning process. Market players are taking advantage of the enhanced healthcare expenditure to expand their market. Prominent players in the market are Pfizer Inc., Olympus Corporation, Abbott Laboratories, The 3M Company, F. Hoffmann-La Roche Ltd, Advanced Sterilization Products Services Inc. (Johnson & Johnson), and Merck & Co., Inc.
The global hospital acquired infections control market is expected to witness robust growth during the forecast period. The number of hospital acquired infections has triggered the need for a separate sterile unit in hospitals where the equipment is sterilized and reprocessed. There are surprise checks by the regulatory authorities to ensure the utilization of sterilized equipment and consumables.
Presence of unhygienic conditions around and inside hospitals and improper sterilization techniques applied in hospitals are increasing the prevalence of hospital acquired infections
Emerging economies such as India, China, Brazil, Mexico and South Africa have a large number of under-served patients. These geographies represent a huge opportunity for medical device manufacturers. Economic development in these emerging economies along with rising disposable income of patients would help the market ensuring future sustainability. Growing healthcare infrastructure and medical expenditure by respective governments would enable installation and usage of sophisticated medical devices such as endoscopes in medical institutions like hospitals. This would increase the demand for endoscope reprocessing devices, as these are capable of disinfecting medical devices efficiently. Likewise, rise in healthcare expenditure would encourage endoscope reprocessing devices manufacturers to enter the market.
Greater focus on development of reprocessors exhibiting innovative product design to avoid cross contamination and enhance patient safety coupled with advancements in the medical device industry is expected to create a favorable platform for innovative reprocessing technologies in high-income economies such as the U.K. and U.S. Companies are expected to benefit from increasing incorporation of innovative technologies in AERs. Such systems are expected to revolutionize the cleaning process in the most effective manner in the near future.
Hospitals are gradually shifting from heat sterilization to low temperature sterilization owing to the various drawbacks related to steam heat sterilizers
The disinfection equipment segment is expected to be the most lucrative among all product types with an attractiveness index of 2.14, while the heat sterilization equipment segment is anticipated to be the second attractive segment in the hospital acquired infections control market, with an attractiveness index of 1.78. Disinfection equipment is the largest product type in the global hospital acquired infections control market, which was estimated to represent US$ 2,585.1 Mn, or 49.6% share of the total market in 2017 and is projected to reach a market valuation of US$ 3,852.5 Mn by 2025 end, expanding at a CAGR of 5.1% over the forecast period 2017–2025.
Guidelines and recommendations of the European Respiratory Society
In this report, we have studied the strategies and key focus areas of players operating in the global hospital acquired infections control market. Provision of efficient after sales services is the primary focus area of players in the global hospital acquired infections control market. Mergers and acquisitions, strategic collaborations and technology transfer agreements play a vital role in the global hospital acquired infections control market. Companies in this market understand the need to meet the requirements of various end users in different facility centers, while ensuring customized services. Quality and positive outcome are of utmost importance to end use industries. It has been noticed that acquisitions and collaborations are the key strategies adopted by global and local players for better service provision and to increase their consumer base in different geographies.
Report structure that incorporates in-depth analysis, key recommendations and overall market viewpoint
An intrinsic part of this report is the analysis and recommendations on the global hospital acquired infections control market. The report takes an overview of the global hospital acquired infections control market and also underlines factors influencing the growth of the global hospital acquired infections control market. The analysts have provided key strategic recommendations for both existing and new players in the market to emerge sustainably profitable. The report covers the competitive landscape that provides a dashboard view of companies that manufacture and provide services in the global hospital acquired infections control market. The report contains company profiles of some of the key players and a strategic overview of mergers and acquisitions along with companies’ expansion plans across regions. Apart from including these factors, the team of expert analysts has also taken into consideration the various macro-economic indicators such as hospital acquired infections control market outlook, gross domestic product and other pointers to arrive at the indicated market numbers.
Top-down approach has been used to counter-validate the final numbers in the global hospital acquired infections control market, while bottom-up approach has been used to assess market numbers in the global hospital acquired infections control market. Weighted average selling price is considered to estimate the market size of various drugs mentioned in the scope of the study. The country price is captured with the local currency. The local currency figures are then converted to USD to offer forecasts in a consistent currency standard.
By Product Type
By End User
Our research methodology incorporates both primary and secondary research to collect the relevant market data. We have analyzed the global hospital acquired infections control market by considering the revenue through extensive primary research to understand the usage patterns, historic trends, problems faced by the medical staff, the required treatment developments, and most preferred products. Key opinion leaders have been considered for the primary research, including experienced healthcare professionals in various healthcare facilities at the country level. These estimates are further validated with product manufacturers, distributors, and suppliers. Extensive secondary research has been carried out to understand the treatment rate, adoption rate, regulatory scenarios, average selling price, and reimbursement scenario by referring to published scientific literature from various databases such as the WHO, PubMed, Springer, and Wiley among others. We have also analyzed various market companies’ annual reports_bk_01_01_2020, investor presentations, SEC filings, 10k reports_bk_01_01_2020 and press releases to fetch substantial information about the market size, trends, opportunities, drivers, restraints and other market dynamics.